newsfilter
← Latest News
GlobeNewswire·

miRagen Announces Major Changes to Company’s Strategy

Expecting topline data in Q3 2020 from truncated Phase 2 SOLAR clinical trial of cobomarsen in CTCL Pursuing guidance from FDA on a clinical development plan for cobomarsen in ATLL; anticipate meeting...